ACM
NEO icon

Aster Capital Management’s NeoGenomics NEO Stock Holding History

Aster Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32
Closed -$376 – 1168
2025
Q4 		$376 Sell
32
-3,309
-99% -$35.7K ﹤0.01% 1027
2025
Q3 		$25.8K Buy
3,341
+997
+43% +$6.98K 0.01% 629
2025
Q2 		$17.1K Sell
2,344
-4,039
-63% -$32.6K ﹤0.01% 729
2025
Q1 		$63.8K Buy
6,383
+6,339
+14,407% +$79.2K 0.01% 745
2024
Q4 		$725 Buy
+44
New +$683 ﹤0.01% 1021

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Aster Capital Management's NEO Position: Q1 2026 in Review

Aster Capital Management sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 32 shares — an estimated $376 sold.

Aster Capital Management first reported a position in NEO in Q4 2024 and held it in 5 quarters. The position peaked at $63.8K in Q1 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Aster Capital Management reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 32 NeoGenomics shares in Q1 2026, an estimated $376.
  • Aster Capital Management first reported a position in NeoGenomics in Q4 2024 and held it in 5 quarters.
  • Aster Capital Management's NeoGenomics position peaked at $63.8K in Q1 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.